The Middle East Conflict and the Global Pharmaceutical Supply Chain: Assessing the Risks of Disruption and Rising Costs.
The escalating war in the Middle East so far has not appreciably disrupted global pharmaceutical...
The escalating war in the Middle East so far has not appreciably disrupted global pharmaceutical...
The Trump administration’s Medicare director, Chris Klomp, confirmed on Thursday that the Centers for Medicare...
The search for a permanent leader of the Centers for Disease Control and Prevention (CDC)...
In a move that has reignited hope for thousands of families across the United Kingdom,...
In a significant legal blow to the health policy directives of the second Trump administration,...
This "tabula rasa" philosophy suggests that because the previous consensus on health policy has been...
In a landmark revelation for the metabolic health landscape, Eli Lilly and Company announced late-stage...
The Food and Drug Administration official in charge of reviewing infectious disease products is leaving...
The landscape of modern oncology was fundamentally shifted with the advent of CAR-T cell therapy,...
The approval of Icotyde comes at a pivotal time for the global pharmaceutical industry, particularly...